Jake Singleton - Joint Corp Chief Officer
| JYNT Stock | USD 11.57 0.22 1.94% |
Executive
Mr. Jake Singleton is Chief Financial Officer of the Company. During his tenure, he was responsible for the full accounting operations of the company, including the production of timely financial statements and related SEC filings, and maintaining a comprehensive set of internal controls designed to mitigate risk and enhance the accuracy of the company reported financial results. He brings technical accounting knowledge, robust experience in SarbanesOxley internal control implementation and compliance, with a strong SEC reporting background that will help guide The Joint Chiropractic in its growth as a public company. Previously, Singleton was a senior manager with Ernst Young. During his 10 years in the Assurance Audit practice, he focused on serving public companies and assisting in raising capital through debt and equity offerings. Singleton also gained international experience in EY Capital Markets transactional accounting group during a twoyear rotation in the United Kingdom, where he focused on US GAAP SEC reporting compliance for foreign entities raising capital in the United States. Singleton received both his Bachelor Degree and Masters of Accounting from the University of Arizona and holds an active Certified Public Accountant license in Arizona and California. since 2018.
| Age | 42 |
| Tenure | 6 years |
| Professional Marks | CPA |
| Address | 16767 North Perimeter Drive, Scottsdale, AZ, United States, 85260 |
| Phone | 480 245 5960 |
| Web | https://www.thejoint.com |
Jake Singleton Latest Insider Activity
Tracking and analyzing the buying and selling activities of Jake Singleton against Joint Corp stock is an integral part of due diligence when investing in Joint Corp. Jake Singleton insider activity provides valuable insight into whether Joint Corp is net buyers or sellers over its current business cycle. Note, Joint Corp insiders must abide by specific rules, including filing SEC forms every time they buy or sell Joint Corp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Jake Singleton over a year ago Payment of 708 shares by Jake Singleton of Joint Corp subject to Rule 16b-3 |
Joint Corp Management Efficiency
The company has return on total asset (ROA) of 0.0201 % which means that it generated a profit of $0.0201 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6046) %, meaning that it created substantial loss on money invested by shareholders. Joint Corp's management efficiency ratios could be used to measure how well Joint Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.14 in 2024. Return On Capital Employed is likely to drop to -0.04 in 2024. Total Current Liabilities is likely to gain to about 35.3 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 46.8 M in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Henry Toledo | ModivCare | N/A | |
| Mary Lacey | Select Medical Holdings | N/A | |
| RN BSN | Enhabit | 67 | |
| Cara Babachicos | InnovAge Holding Corp | N/A | |
| Mark Brewer | Enhabit | N/A | |
| Nicole DAmato | InnovAge Holding Corp | 45 | |
| Barbara CPA | ModivCare | 61 | |
| Dylan Black | Enhabit | 55 | |
| Kenneth Shepard | ModivCare | 43 | |
| Zachary CFA | ModivCare | N/A | |
| Oleg Mikulinsky | CryoCell International | 51 | |
| FACP MD | InnovAge Holding Corp | 57 | |
| Matt Huray | InnovAge Holding Corp | N/A | |
| Benjamin Adams | InnovAge Holding Corp | 60 | |
| Christine Bent | InnovAge Holding Corp | 54 | |
| Shelly Eckenroth | Select Medical Holdings | N/A | |
| Timothy Shelly | National HealthCare | N/A | |
| Lynette CPA | Pennant Group | 46 | |
| Chad JD | The Ensign Group | 46 | |
| Kirk Cheney | Pennant Group | N/A | |
| Dustin Lee | InnovAge Holding Corp | N/A | |
Management Performance
| Return On Equity | -0.6 | ||||
| Return On Asset | 0.0201 |
Joint Corp Leadership Team
Elected by the shareholders, the Joint Corp's board of directors comprises two types of representatives: Joint Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Joint. The board's role is to monitor Joint Corp's management team and ensure that shareholders' interests are well served. Joint Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Joint Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Beth Gross, Senior Resources | ||
| Jorge Armenteros, Senior Operations | ||
| Jason Greenwood, Chief Officer | ||
| Jake CPA, Chief Officer | ||
| Lori Habib, Chief Officer | ||
| Charles Nelles, Chief Officer | ||
| Jake Singleton, Chief Officer | ||
| Sanjiv Razdan, President CEO | ||
| Steven Knauf, Vice Compliance | ||
| Craig JD, Secretary | ||
| Eric Simon, Senior Development | ||
| Peter Holt, President CEO | ||
| Krischelle Tennessen, Chief Officer | ||
| Manjula Sriram, Vice Technology |
Joint Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Joint Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.6 | ||||
| Return On Asset | 0.0201 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 158.75 M | ||||
| Shares Outstanding | 14.98 M | ||||
| Shares Owned By Insiders | 1.78 % | ||||
| Shares Owned By Institutions | 73.22 % | ||||
| Number Of Shares Shorted | 487.26 K | ||||
| Price To Earning | 16.57 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Joint Stock Analysis
When running Joint Corp's price analysis, check to measure Joint Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Joint Corp is operating at the current time. Most of Joint Corp's value examination focuses on studying past and present price action to predict the probability of Joint Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Joint Corp's price. Additionally, you may evaluate how the addition of Joint Corp to your portfolios can decrease your overall portfolio volatility.